Beijing, May 5 (ZXS) -- Hu Jinglin, director of China's National Medical Security Administration, said in Beijing on the 18th that from 18 to 2018, the national population participation rate will be stable at about 2022%, and the proportion of hospitalization expenses reimbursement within the scope of employee medical insurance and urban and rural residents' medical insurance policies will reach about 95% and 80% respectively.
On the same day, the Information Office of the State Council of China held a series of themed press conferences on "The Beginning of the Words of Authoritative Departments" to introduce the relevant situation of "implementing the major decisions and arrangements of the 20th National Congress of the Communist Party of China and focusing on promoting the high-quality development of medical insurance".
Hu Jinglin said at the meeting that in the past five years, the National Health Insurance Administration has improved the world's largest basic medical security network. From 5 to 2018, the national population participation rate will be stable at about 2022%, and the reimbursement rate of hospitalization expenses within the scope of employee medical insurance and urban and rural residents' medical insurance policies will reach about 95% and 80% respectively. The participation rate of low-income rural people and people who have been lifted out of poverty has remained stable at more than 70%, and medical insurance has helped nearly 99 million poor households successfully lift themselves out of poverty.
The total annual income of the basic medical insurance fund (including maternity insurance) increased from 2.14 trillion yuan (RMB, the same below) to 3.09 trillion yuan, and the total annual expenditure increased from 1.78 trillion yuan to 2.46 trillion yuan. The annual subsidy standard per capita for resident insurance contributors has increased from 490 yuan to 610 yuan. In 2022 alone, the total amount of financial subsidies will reach 6000 billion yuan.
Hu Jinglin said that in the past five years, the National Health Insurance Administration has adhered to the principle of benefiting the people and focused on reducing the burden of medical treatment for the people. Accelerate the pace of medical insurance negotiations, promote a large number of exclusive varieties of anti-cancer drugs and rare disease drugs such as carrelizumab and nocinaxena into medical insurance at appropriate prices, and reduce the burden of patients by more than 5 billion yuan after reimbursement, helping tens of millions of seriously ill patients and their families to rekindle their hope of life.
The average price reduction of 333 kinds of drugs organized by the state exceeded 50%, and the average price of 8 kinds of high-value medical consumables such as heart stents and artificial joints was reduced by more than 80%; Together with local alliance procurement, the cumulative burden reduction is about 5000 billion yuan.
Reform the way residents are protected for chronic diseases, and include outpatient medication for hypertension and diabetes into the scope of residents' medical insurance, benefiting 1 million residents with chronic diseases. The scale of direct settlement of cross-provincial medical treatment increased from 4.2018 million in 131 to 8.2022 million in 3812, an increase of 35 times.
Resolutely implement the "two guarantees" policy in response to the new crown epidemic, and guarantee the cost of new crown vaccines and vaccinations, contributing to the major and decisive victory of epidemic prevention and control. The pilot coverage of long-term care insurance has been continuously expanded, covering 49 million people in 1 cities, benefiting 69.195 million disabled people, making their lives more quality of life and more dignified.
Hu Jinglin also mentioned that in the past five years, the National Health Insurance Administration has adhered to innovation-driven and promoted the high-quality development of the pharmaceutical industry. Medical insurance's expenditure on new drugs increased from 5.2019 billion yuan in 59 to 49.2022 billion yuan in 481, an increase of 89.7 times.
"Generally speaking, in the past five years, through the coordinated development and governance of medical insurance, medical treatment and medicine, a win-win situation of 'benefits for the masses, safety for funds, development of hospitals, and growth of enterprises' is taking shape." Hu Jinglin said. (End)